Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003–2011
Open Access
- 4 August 2015
- journal article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 9 (5) , 225-233
Abstract
Background: Hospitalization burden associated with influenza and respiratory syncytial virus (RSV) is uncertain due to ambiguity in the inference methodologies employed for its estimation.Objectives: Utilization of a new method to quantitate the above burden.Methods: Weekly hospitalization rates for several principal diagnoses from 2003 to 2011 in New York City by age group were regressed linearly against incidence proxies for the major influenza subtypes and RSV adjusting for temporal trends and seasonal baselines.Results: Average annual rates of influenza‐associated respiratory hospitalizations per 100 000 were estimated to be 129 [95% CI (79, 179)] for age <1, 36·3 (21·6, 51·4) for ages 1–4, 10·6 (7·5, 13·7) for ages 5–17, 25·6 (21·3, 29·8) for ages 18–49, 65·5 (54·0, 76·9) for ages 50–64, 125 (105, 147) for ages 65–74, and 288 (244, 331) for ages ≥75. Additionally, influenza had a significant contribution to hospitalization rates with a principal diagnosis of septicemia for ages 5–17 [0·76 (0·1, 1·4)], 18–49 [1·02 (0·3, 1·7)], 50–64 [4·0 (1·7, 6·3)], 65–74 [8·8 (2·2, 15·6)], and ≥75 [38·7 (25·7, 52·9)]. RSV had a significant contribution to the rates of respiratory hospitalizations for age <1 [1900 (1740, 2060)], ages 1–4 [117 (70, 167)], and ≥75 [175 (44, 312)] [including chronic lower respiratory disease, 90 (43, 140)] as well as pneumonia & influenza hospitalizations for ages 18–49 [6·2 (1·1, 11·3)] and circulatory hospitalizations for ages ≥75 [199 (13, 375)].Conclusions: The high burden of RSV hospitalizations among young children and seniors age ≥75 suggests the need for additional control measures such as vaccination to mitigate the impact of annual RSV epidemics. Our estimates for influenza‐associated hospitalizations provide further evidence of the burden of morbidity associated with influenza, supporting current guidelines regarding influenza vaccination and antiviral treatment.Keywords
Funding Information
- National Institutes of Health (1K01AI101010-01)
- National Institute of General Medical Sciences (U54GM088558)
This publication has 28 references indexed in Scilit:
- Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for CanadaInfluenza and Other Respiratory Viruses, 2012
- The Art of Modeling the Mortality Impact of Winter-Seasonal PathogensThe Journal of Infectious Diseases, 2012
- Mortality Attributable to 9 Common Infections: Significant Effect of Influenza A, Respiratory Syncytial Virus, Influenza B, Norovirus, and Parainfluenza in Elderly PersonsThe Journal of Infectious Diseases, 2012
- Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008Clinical Infectious Diseases, 2012
- Circulating Influenza Virus, Climatic Factors, and Acute Myocardial Infarction: A Time Series Study in England and Wales and Hong KongThe Journal of Infectious Diseases, 2011
- Confounding by Season in Ecologic Studies of Seasonal Exposures and Outcomes: Examples From Estimates of Mortality Due to InfluenzaAnnals of Epidemiology, 2009
- The Need for Validation of Statistical Methods for Estimating Respiratory Virus-Attributable HospitalizationAmerican Journal of Epidemiology, 2009
- Estimates of US influenza‐associated deaths made using four different methodsInfluenza and Other Respiratory Viruses, 2009
- Monitoring the Impact of Influenza by Age: Emergency Department Fever and Respiratory Complaint Surveillance in New York CityPLOS Medicine, 2007
- Influenza- and RSV-associated hospitalizations among adultsVaccine, 2007